FDA Approved: LEQEMBI — Supplemental Application (Eisai Inc.)

View source ↗

Summary

FDA page describing Eisai's supplemental application for LEQEMBI (lecanemab) and its regulatory submission status. The entry identifies the drug and manufacture…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEQEMBI (lecanemab)

Snippet

SUPPL AP for LEQEMBI (LECANEMAB)